US Congress House Bill 1034 (Prior Session Legislation)

---

Spectrum: Moderate Partisan Bill (Republican 61-17)
Status: Introduced on February 7 2019 - 25% progression, died in committee
Action: 2019-02-07 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Requires that certain negotiated prices for covered drugs under the Medicare prescription drug benefit be disclosed at the point-of-sale. Specifically, negotiated prices offered under a prescription drug plan (PDP) must be disclosed at the point-of-sale; the disclosed price must include specified adjustments, payments, and fees that are negotiated with the pharmacy (e.g., dispensing fees) by the PDP sponsor or pharmacy benefit manager. Additionally, the Centers for Medicare & Medicaid Services must establish certain quality measures for PDP sponsors to use when determining incentive payments and adjustments (e.g., performance payments) to pharmacies.

Phair Pricing Act of 2019

Rep. Doug Collins [R-GA]	Rep. Vicente Gonzalez [D-TX]	Rep. David Roe [R-TN]	Rep. Robert Wittman [R-VA]
Rep. Austin Scott [R-GA]	Rep. Bruce Westerman [R-AR]	Rep. Morgan Griffith [R-VA]	Rep. Will Hurd [R-TX]
Sen. Ted Budd [R-NC]	Rep. Eric Crawford [R-AR]	Rep. Earl Carter [R-GA]	Rep. Tom Graves [R-GA]
Sen. Roger Marshall [R-KS]	Rep. Louie Gohmert [R-TX]	Rep. Bradley Byrne [R-AL]	Rep. Martha Roby [R-AL]
Rep. Filemon Vela [D-TX]	Rep. Barry Loudermilk [R-GA]	Rep. Mike D. Rogers [R-AL]	Rep. Lance Gooden [R-TX]
Rep. Garret Graves [R-LA]	Rep. Mark Meadows [R-NC]	Rep. Jody Hice [R-GA]	Rep. John Joyce [R-PA]
Rep. Clay Higgins [R-LA]	Rep. C.A. Ruppersberger [D-MD]	Rep. Steve King [R-IA]	Sen. Peter Welch [D-VT]
Rep. David Loebsack [D-IA]	Rep. Jared Golden [D-ME]	Rep. Chris Stewart [R-UT]	Rep. Andy Harris [R-MD]
Rep. Jaime Herrera Beutler [R-WA]	Rep. Steve Womack [R-AR]	Rep. Kelly Armstrong [R-ND]	Rep. Michael Guest [R-MS]
Rep. Sean Duffy [R-WI]	Rep. David Rouzer [R-NC]	Rep. Chris Collins [R-NY]	Rep. Ben Cline [R-VA]
Rep. Rick Allen [R-GA]	Rep. Ralph Abraham [R-LA]	Rep. Charles Fleischmann [R-TN]	Rep. Cathy McMorris Rodgers [R-WA]
Rep. Henry Johnson [D-GA]	Rep. Kathleen Rice [D-NY]	Rep. Henry Cuellar [D-TX]	Rep. Abby Finkenauer [D-IA]
Rep. Sharice Davids [D-KS]	Rep. Bill Posey [R-FL]	Rep. David McKinley [R-WV]	Rep. Lisa Rochester [D-DE]
Rep. Anthony Brindisi [D-NY]	Rep. French Hill [R-AR]	Rep. John Rutherford [R-FL]	Rep. Ralph Norman [R-SC]
Rep. Fred Keller [R-PA]	Rep. Mike Gallagher [R-WI]	Rep. Peter King [R-NY]	Rep. Bob Gibbs [R-OH]
Rep. Cindy Axne [D-IA]	Rep. Mo Brooks [R-AL]	Rep. Billy Long [R-MO]	Rep. Tom Cole [R-OK]
Rep. James Comer [R-KY]	Rep. David Kustoff [R-TN]	Rep. Vicky Hartzler [R-MO]	Rep. Jeff Van Drew [R-NJ]
Rep. Kendra Horn [D-OK]	Rep. Greg Steube [R-FL]	Rep. Zoe Lofgren [D-CA]	Rep. Glenn Thompson [R-PA]
Rep. Mike Johnson [R-LA]	Rep. Matthew Cartwright [D-PA]	Rep. Trent Kelly [R-MS]	Rep. Ross Spano [R-FL]
Rep. John Rose [R-TN]	Rep. Tim Burchett [R-TN]

Date	Chamber	Action
2019-02-07	House	Referred to the Subcommittee on Health.
2019-02-07	House	Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-02-07	House	Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-02-07	House	Introduced in House

SB640 (Same As) 2019-03-04 - Read twice and referred to the Committee on Finance.

Type	Source
Summary	https://www.congress.gov/bill/116th-congress/house-bill/1034/all-info
Text	https://www.congress.gov/116/bills/hr1034/BILLS-116hr1034ih.pdf